Umifenovir

SKU: orb1310932

Featured

Description

Umifenovir hydrochloride (Arbidol HCl) is a broad-spectrum antiviral small molecule that inhibits the entry of enveloped viruses by preventing viral-host cell membrane fusion. It has demonstrated antiviral activity in vitro and in vivo against influenza, coronaviruses, and other viruses, making it a useful tool for virology and antiviral mechanism research.

Research Area

Pharmacology & Drug Discovery

Images & Validation

−

Key Properties

−

CAS Number	131707-23-8
MW	513.9
Purity	>98%
Formula	C₂₂H₂₅BrN₂O₃S • HCl
SMILES	Cl.CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12
Target	SARS-CoV,Influenza Virus
Solubility	Soluble in DMSO (up to at least 15 mg/ml) or in Ethanol (up to at least 10 mg/ml)

Bioactivity

−

Target IC50

RNA viruses(FLU-A, RSV, HRV 14 and CVB3, enveloped and non-enveloped):2.7-13.8 microg/ml

In Vitro

Arbidol inhibits the cell entry of HCV pseudoparticles of genotypes 1a, 1b, and 2a in a dose-dependent fashion. Arbidol also displays a dose-dependent inhibition of HCV membrane fusion, as assayed by using HCV pseudoparticles (HCVpp) and fluorescent liposomes. Arbidol is found to present potent inhibitory activity against enveloped and non-enveloped RNA viruses, including FLU-A, RSV, HRV 14 and CVB3 when added before, during, or after viral infection, with IC50 ranging from 2.7 to 13.8 mg/mL. Arbidol shows selective antiviral activity against AdV-7, a DNA virus, only when added after infection (therapeutic index (TI) = 5.5). Arbidol induces changes to viral mRNA synthesis of the PB2, PA, NP, NA, and NS genes in MDCK cultures infected with influenza A/PR/8/34. Arbidol interacts and modifies the physicochemical properties of the phospholipids in the membrane, having a significant effect on negatively charged phospholipids but a minor one on zwitterionic phospholipids. Arbidol is located at the interface of the membrane, participates in hydrogen bonding either with water or the phospholipid or both, and decreases the hydrogen bonding network of the phospholipids giving place to a phospholipid phase similar to the dehydrated solid one. Arbidol is found to have potent inhibitory activity against HTNV when added in vitro before or after viral infection, with IC50 of 0.9 mg/mL and 1.2 mg/mL, respectively.

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Arbidol

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

9958103 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Umifenovir (orb1310932)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

CAS Number:	2928218-29-3
MW:	519.91
Formula:	C₂₂H₂₀D₆BrClN₂O₃S

Purity:	99.57% (May vary between batches)
CAS Number:	131707-25-0
MW:	477.42
Formula:	C₂₂H₂₅BrN₂O₃S

CAS Number:	868364-57-2
MW:	531.89
Formula:	C₂₂H₂₈BrClN₂O₄S

Purity:	greater than or equal to 98% (HPLC)
CAS Number:	131707-23-8
MW:	477.4 . 36.5
Formula:	C₂₂H₂₅BrN₂O₃S . HCl

Purity:	>98% (HPLC)
CAS Number:	131707-25-0
MW:	477.42
Formula:	C₂₂H₂₅BrN₂O₃S

Umifenovir

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

Arbidol-d6 Hydrochloride [orb2300221]

Arbidol [orb1685431]

Umifenovir hydrochloride monohydrate [orb1740987]

Umifenovir . HCl [Arbidol] [orb1227511]

Arbidol [orb2900414]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

Umifenovir (orb1310932)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors